The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said.

While demand for COVID-19 shots in the US has dropped off dramatically, the need for more vaccines around the world remains critical. The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting vaccine supplies in the developing world.

The company's vaccine can be stored in standard refrigerators, making it easier to distribute than the vaccines that are already being widely used in the US.

Novavax previously announced manufacturing delays due to supply shortages. The company now expects to reach production of 100 million doses a month by the end of September and 150 million doses a month by December.

The company has committed to supplying 110 million doses to the US over the next year and a total of 1.1 billion doses to developing countries.

"Many of our first doses will go to ... low-and middle-income countries, and that was the goal to begin with," Novavax Chief Executive Stanley Erck told The Associated Press.

While more than half of the US population has had at least one COVID-19 vaccine dose, less than 1 percent of people in the developing world have had one shot, according to Our World In Data.

Novavax's study involved nearly 30,000 people ages 18 and up in the US and Mexico. Two-thirds received two doses of the vaccine, three weeks apart, and the rest got a placebo instead.

There were 77 cases of COVID-19. Fourteen in the group got the vaccine and the rest were volunteers who received the inactive substance. None in the vaccine group had moderate or severe COVID, compared to 14 in the placebo group.

The vaccine was similarly effective against several variants including the one first detected in the UK that's dominant in the US, and in high-risk populations including the elderly and people with other health problems.

Side effects were mostly mild, including tenderness and pain at the injection site. There were no reports of unusual blood clots or heart problems, Erck said.

Novavax reported the results in a press release and plans to publish in a medical journal, where it will be vetted by independent experts. The Maryland-based company previously released findings from smaller studies in Britain and South Africa.

COVID-19 vaccines train the body to recognize the coronavirus, especially the spike protein that coats it, creating an immune system defense to help fight the virus off. The Novavax vaccine is made with lab-grown copies of that protein. That's different from some of the other vaccines now widely used, which include genetic instructions for the body to make its own spike protein.

Last month, vaccines alliance Gavi announced it had signed an agreement to buy 350 million doses of Novavax’s vaccine, with deliveries estimated to begin in the third quarter. COVAX, the global initiative to provide vaccines to countries, is facing a critical shortage of vaccines after its biggest supplier in India suspended exports until the end of the year.

Novavax has been working on developing vaccines for more than three decades but hasn't brought one to market. The company’s coronavirus vaccine work is partly funded by the US government. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

5 Key Signs to Spot a Human Trafficking Victim

CDC's Major Change on COVID-19 Vax; Lets Individuals Decide, and Makes Chickenpox Vaccine Standalone

COVER-UP EXPOSED: Declassified Docs Reveal Then-VP Biden Suppressed Report on Family's Foreign Entanglements

Another Scandal Threatens to Shake up Virginia's Elections

Dems Back Virginia AG Candidate Despite 'Violent, Disgusting, Disqualifying' Texts about Killing Republicans, and Their Children

Pam Bondi Tears into Illinois' Dem Senator: 'I Wish You Loved Chicago as Much as You Hate President Trump'

White House Slams 'Sick' Chicago Mayor Brandon Johnson After His Latest Anti-ICE Move

Portland DA Drops Charges against Conservative Journalist Who Was Attacked by Antifa

Battered, Yet Strong: With Christian and US Support, Israelis Mark 2 Years Since October 7th Atrocities

Leftists Try to Shut Down Pro-Charlie Kirk Coffee Shop: 'But God is Good'

Dr. Jordan Peterson Was 'Near Death' Over the Summer

'Playing God': Shocking Research Turns Skin Cells into Human Eggs [Video]

'Unacceptable': Despite Promising a Safety Review, FDA Approves Another Generic Abortion Pill

Mainstream Media Goes All in on Woke Pronouns over Chief Justice Kavanaugh's Would-Be Assassin

Rank-And-File DC Officers Accuse Superiors of Downgrading Crimes to Mask Real Levels: Report

Trump's Deployment of National Guard Troops to Handle Antifa in Portland Halted by Federal Judge

Israeli Delegation Heads to Egypt for Hostage Talks with Hamas

Good News: TPUSA High School Clubs More Than Double, Hit 2,700 Nationwide

Atheist Bill Maher Condemns Media Silence on Christian Genocide in Nigeria: 'Systematic Killing'

'We Found Him': The Alleged Smoke Bomber Who Disrupted a Sean Feucht Worship Event; His Shocking Links to Antifa Inside Canada's Military